| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 23/11/2011 | 22h10 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 23/11/2011 | 20h01 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 23/11/2011 | 07h39 | Dow Jones News | Roche Buys Shares In Tender Offer For Anadys Pharmaceuticals | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 16/11/2011 | 12h02 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 15/11/2011 | 23h10 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 14/11/2011 | 22h55 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 09/11/2011 | 12h05 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 09/11/2011 | 12h05 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 08/11/2011 | 14h16 | Marketwired | Acquisition Spotlight Shines on Hepatitis C Drug Developers | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 07/11/2011 | 23h01 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 07/11/2011 | 22h05 | PR Newswire (US) | Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 04/11/2011 | 21h34 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 31/10/2011 | 14h30 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 26/10/2011 | 14h16 | Marketwired | Positive Test Results and Acquisitions Drive Shares of Exelixis and Anadys Higher | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 26/10/2011 | 12h02 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 25/10/2011 | 23h08 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 25/10/2011 | 22h25 | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 25/10/2011 | 15h34 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 24/10/2011 | 22h55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 21/10/2011 | 16h53 | Business Wire | The Law Firm of Weiss & Lurie Investigates Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 20/10/2011 | 21h39 | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 20/10/2011 | 15h30 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 20/10/2011 | 12h08 | Dow Jones News | Roche MS Drug's Good Test Results Boost Pipeline's Prospects | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 20/10/2011 | 01h00 | Business Wire | Faruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 19/10/2011 | 23h14 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 19/10/2011 | 22h11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 19/10/2011 | 19h12 | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Anadys Pharmaceuticals Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 19/10/2011 | 05h30 | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 18/10/2011 | 15h00 | Marketwired | Analyst View, Impact of Global Events - Research Report on Anadys Pharmaceuticals, Inc. and Kinder Morgan Energy Partners LP | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |
| 18/10/2011 | 02h32 | Business Wire | Robbins Umeda LLP Announces an Investigation of Anadys Pharmaceuticals, Inc. | NASDAQ:ANDS | Anadys Pharmaceuticals (MM) |